Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

314 Views

H2. HIV: Prevention

Poster Session: HIV: Prevention

(P-529) Comparison of Renal Outcomes by Tenofovir Alafenamide Fumarate (TAF) vs. Tenofovir Disoproxil Fumarate (TDF) Containing Regimens for Prevention, and Treatment of HIV and/or HBV Treatment: A Systematic Literature Review and Meta-Analysis

Thursday, October 17, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

XL

Xi Liang, PharmD (she/her/hers)

PhD candidate
University of Utah College of Pharmacy
Salt Lake City, Utah, United States

Co-Author(s)

KP

Kyu Yun Park, PharmD

University of Utah College of Pharmacy
Salt Lake City, Utah, United States
HL

Haeseon Lee, PharmD, MSc

University of Utah College of Pharmacy
Salt Lake City, Utah, United States
CW

Connor Willis, PharmD

University of Utah College of Pharmacy
Salt Lake City, Utah, United States
TD

Tara Dhippayom, High School Student

The Prince Royal's College
Chiang Mai, Chiang Mai, Thailand
RR

Rachel Rogers
AW

Amy Weinberg, DNP, MS

Senior Director
Gilead Sciences, Inc.
Foster City, California, United States
JG

Julia Green, MS, APRN, AGNP-C, ACRN, AAHIVE

Gilead Sciences, Inc.
Foster City, California, United States
AC

Aileen Chi, PharmD

Gilead Sciences, Inc.
Foster City, California, United States
NC

Nathorn Chaiyakunapruk, PhD

University of Utah
Salt Lake City, Utah, United States